Endo Pleads Guilty To Marketing Opioids As 'Crush Proof'

By Danielle Ferguson · April 18, 2024, 5:48 PM EDT

Endo Health Solutions Inc. pled guilty Thursday in Michigan federal court to putting out a drug it falsely advertised as being "crush proof" and "abuse deterrent," part of its larger agreement...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

United States of America v. Endo Health Solutions Inc.

Case Number

Court

Michigan Eastern

Nature of Suit

Date Filed

March 27, 2024

Recent Articles By Danielle

May 15, 2024
Worker Updates Boot-Up Suit After Judge Axes State Claims
May 02, 2024
Endo Judge Hopes Criminal Sentence Warns Opioid Makers
April 12, 2024
Mich. Hospital Must Face MedMal Suit Against Contract Doc
April 05, 2024
Mich. Plaintiffs Bar Prepares For Growth After Policy Shifts
April 01, 2024
Ford Can Keep Pursuing Narrowed BCBS Antitrust Suit
February 16, 2024
Fired Hospital Worker Can't Keep Fighting PTO Denial
February 08, 2024
Mich. Counties Sue Drug Giants Over Insulin Prices
January 30, 2024
Tribe's Repeat Default Bids Disrespect Court, Blue Cross Says
January 29, 2024
Insurer-Backed Docs Must Show Tax Records For Bias Check
January 16, 2024
Embattled Burger Chain Not Paying Property Taxes, Suit Says